IMOCOLIBOV
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
18-04-2024
Send request.
Active ingredient:
INACTIVATED E.COLI (ANTIGEN K99), INACTIVATED E.COLI (ANTIGEN Y), INACTIVATED E.COLI (ANTIGEN 31A), INACTIVATED E.COLI SEROTYPE 09, INACTIVATED E.COLI SEROTYPE 08, INACTIVATED E.COLI SEROTYPE 015, INACTIVATED E.COLI SEROTYPE 078, INACTIVATED E.COLI SEROTYPE 0101, INACTIVATED E.COLI SEROTYPE 00117
Available from:
Merial Animal Health Limited
ATC code:
QI02AC
INN (International Name):
INACTIVATED E.COLI (ANTIGEN K99), INACTIVATED E.COLI (ANTIGEN Y), INACTIVATED E.COLI (ANTIGEN 31A), INACTIVATED E.COLI SEROTYPE
Dosage:
Per Cent
Pharmaceutical form:
Suspension for Injection
Prescription type:
LM-Licensed Merchant
Therapeutic group:
Bovine, Ovine
Therapeutic area:
Inactivated bacterial vaccines and antisera QI04AC Inactivated bacterial vaccines and antisera
Therapeutic indications:
Immunological - Inactivated vaccine
Authorization status:
Authorised
Authorization date:
2003-08-06
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA: 10857/033/001
Case No: 7004886
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
MERIAL ANIMAL HEALTH LIMITED
SANDRINGHAM HOUSE, SANDRINGHAM AVENUE, HARLOW BUSINESS PARK, HARLOW, ESSEX CM19 5TG, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
IMOCOLIBOV
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
The authorisation,unless revoked, shall continue in force from 22/09/2008.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 23/09/2008_
_CRN 7004886_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
IMOCOLIBOV
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml of vaccine contains _E. coli _somatic serotypes 09, 08, 015, 078, 0101, 0117, expressing virulence factors:
Active substances:
* 1 SA.U: q.s. to obtain an agglutinating antibody titre of 1 log 10 in guinea-pigs after two administrations of vaccine.
** OD – Optical Density
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
Read the complete document
